Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Generic penetration rate by value in France by market size 2008-2014

Market share of generic medicines in value in France from 2008 to 2014, by market size

by Statista Research Department, last edited Sep 1, 2015
Generic penetration rate by value in France by market size 2008-2014 This statistic shows the penetration rate of generic drugs in France from 2007 to 2014, depending on the size of the market. In 2014, the share of the value of generics in the total drug market was just over 18 percent.
Show more

Market share of generic medicines in value in France from 2008 to 2014, by market size

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical market in Italy"
  • Market overview
The most important statistics
  • Pharmacy figures
  • Pharmaceutical expenditure
  • Pharmaceutical consumption
  • Brand name and generic drugs
  • Nonprescription drugs
  • Health supplements
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.